Evidence map›Paper›PMID 29509834›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease-United States, 2009-2015.

Heidi M Soeters, Amy Blain, Tracy Pondo, Brooke Doman, Monica M Farley, Lee H Harrison, Ruth Lynfield, Lisa Miller, Susan Petit, Arthur Reingold and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it, 0 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Infant protection from invasiveHuman vaccines & immunotherapeutics · 2025
    Review
  10. Article
  11. Observational
  12. Review
  13. AASM case reports · 2025
    Article
  14. Article
  15. Article
  16. European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  17. Article
  18. Exploiting haem-iron dependence of nontypeableFrontiers in cellular and infection microbiology · 2025
    Review
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 1 country.

Heidi M SoetersEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
Amy BlainNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Tracy PondoNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Brooke DomanNew Mexico Department of Health, Santa Fe.
Monica M FarleyEmory University School of Medicine, Georgia.
Lee H HarrisonJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Ruth LynfieldMinnesota Department of Health, St. Paul.
Lisa MillerUniversity of Colorado School of Public Health, Denver.
Susan PetitConnecticut Department of Public Health, Hartford.
Arthur ReingoldSchool of Public Health, University of California, Berkeley.
William SchaffnerVanderbilt University School of Medicine, Nashville, Tennessee.
Ann ThomasOregon Health Authority, Portland.
Shelley M ZanskyNew York State Department of Health, Albany.
Xin WangNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Elizabeth C BriereNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Centers for Disease Control and Prevention · USNational Center for Immunization and Respiratory Diseases · USColorado School of Public Health · USConnecticut Department of Public Health · USEmory University · USJohns Hopkins University · USMinnesota Department of Health · USNew Mexico Department of Health · USNew York State Department of Health · USOregon Health Authority · USUniversity of California, Berkeley · USVanderbilt University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Background: Following Haemophilus influenzae serotype b (Hib) conjugate vaccine introduction in the 1980s, Hib disease in young children dramatically decreased, and epidemiology of invasive H. influenzae changed. Methods: Active surveillance for invasive H. influenzae disease was conducted through Active Bacterial Core surveillance sites. Incidence rates were directly standardized to the age and race distribution of the US population. Results: During 2009-2015, the estimated mean annual incidence of invasive H. influenzae disease was 1.70 cases per 100000 population. Incidence was highest among adults aged ≥65 years (6.30) and children aged <1 year (8.45); many cases in infants aged <1 year occurred during the first month of life in preterm or low-birth-weight infants. Among children aged <5 years (incidence: 2.84), incidence was substantially higher in American Indian and Alaska Natives AI/AN (15.19) than in all other races (2.62). Overall, 14.5% of cases were fatal; case fatality was highest among adults aged ≥65 years (20%). Nontypeable H. influenzae had the highest incidence (1.22) and case fatality (16%), as compared with Hib (0.03; 4%) and non-b encapsulated serotypes (0.45; 11%). Compared with 2002-2008, the estimated incidence of invasive H. influenzae disease increased by 16%, driven by increases in disease caused by serotype a and nontypeable strains. Conclusions: Invasive H. influenzae disease has increased, particularly due to nontypeable strains and serotype a. A considerable burden of invasive H. influenzae disease affects the oldest and youngest age groups, particularly AI/AN children. These data can inform prevention strategies, including vaccine development.

Indexed as

Epidemiological MonitoringAdolescentAdultAgedAge FactorsChildChild, PreschoolCost of IllnessFemaleHaemophilus InfectionsHaemophilus influenzaeHaemophilus influenzae type bHaemophilus VaccinesHumansIncidenceInfantHaemophilus Vaccines

Identifiers

PMID29509834
PMCPMC6181225
OpenAlexW2585527851

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.